Intraepidermal nerve-fibre density as a biomarker of the course
of neuropathy in patients with Type2 diabetes mellitus

J 2016

Intraepidermal nerve-fibre density as a biomarker of the course of neuropathy in patients with Type2 diabetes mellitus

DIVIŠOVÁ, Šárka; Eva VLČKOVÁ; Iva ŠROTOVÁ; Soňa KINCOVÁ; M. SKORNA et al.

Základní údaje

Originální název

Intraepidermal nerve-fibre density as a biomarker of the course of neuropathy in patients with Type2 diabetes mellitus

Autoři

DIVIŠOVÁ, Šárka; Eva VLČKOVÁ; Iva ŠROTOVÁ; Soňa KINCOVÁ; M. SKORNA; Ladislav DUŠEK; Petr DUBOVÝ a Josef BEDNAŘÍK

Vydání

Diabetic Medicine, Hoboken, Wiley-Blackwell, 2016, 0742-3071

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30000 3. Medical and Health Sciences

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 3.054

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/16:00090718

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

PERIPHERAL NEUROPATHY; NORMATIVE DATA; SKIN BIOPSY; DIAGNOSIS

Štítky

EL OK, podil

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 6. 9. 2016 14:38, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

Aims This paper aims to investigate whether intraepidermal nerve-fibre density (IENFD) may be used as a marker of the course of neuropathy in patients with Type2 diabetes mellitus. Methods Skin biopsies from the distal leg were serially evaluated in a group of 30 patients with Type2 diabetes mellitus (median age 60years, 17 men) with a short duration of diabetes (<3years) and good glucose control, and in 23 age- and sex-matched controls. The time intervals between biopsies were >2years (median 33.8months). Eighteen patients with Type2 diabetes mellitus had symptoms or signs of distal symmetrical diabetic polyneuropathy, 12 had no neuropathy. Results At first skin biopsy, IENFD was normal in all controls and in patients without neuropathy (mean 9.5 and 7.9fibres/mm, respectively) compared with abnormal IENFD in 77.8% in patients with polyneuropathy (mean 3.4fibres/mm). The annual rate of intraepidermal nerve-fibre (IENF) loss expressed as a percentage of the first IENFD value in patients with diabetic polyneuropathy was significantly higher [mean (se), 11.95 (3.82)%] compared with controls [1.92 (1.81)%, P<0.001] and similar to patients without polyneuropathy [12.16 (4.38)%]. The rate of IENF loss did not correlate with degree of glucose control. Conclusions The annual rate of IENF loss in patients with Type2 diabetes mellitus was several times higher than that of healthy participants, irrespective of the presence of signs or symptoms of diabetic polyneuropathy at initial evaluation. The change in IENFD is not linear and should be expressed as a proportion of initial IENFD to serve as a marker of the course of diabetic neuropathy. What's new? Intraepidermal nerve-fibre loss in patients with Type2 diabetes mellitus is not linear and should be expressed as a proportion of initial intraepidermal nerve-fibre density. Annual intraepidermal nerve-fibre loss as a marker of the progression of small-fibre neuropathy in patients with Type2 diabetes mellitus is several times higher compared with age-related intraepidermal nerve-fibre loss in age- and sex-matched people without diabetes. Change in intraepidermal nerve-fibre density in patients with Type2 diabetes mellitus of short duration and good glucose control is not dependent on the presence of neuropathy and degree of glucose control.

Návaznosti

ED1.1.00/02.0068, projekt VaV

Název: CEITEC - central european institute of technology

Přiložené soubory

EL_1353344.pdf

Požádat o autorskou verzi souboru

Citovat

DIVIŠOVÁ, Šárka; Eva VLČKOVÁ; Iva ŠROTOVÁ; Soňa KINCOVÁ; M. SKORNA; Ladislav DUŠEK; Petr DUBOVÝ a Josef BEDNAŘÍK. Intraepidermal nerve-fibre density as a biomarker of the course of neuropathy in patients with Type2 diabetes mellitus. Diabetic Medicine. Hoboken: Wiley-Blackwell, 2016, roč. 33, č. 5, s. 650-654. ISSN 0742-3071. Dostupné z: https://doi.org/10.1111/dme.12890.

@article{1353344,
   author = {Divišová, Šárka and Vlčková, Eva and Šrotová, Iva and Kincová, Soňa and Skorna, M. and Dušek, Ladislav and Dubový, Petr and Bednařík, Josef},
   article_location = {Hoboken},
   article_number = {5},
   doi = {https://doi.org/10.1111/dme.12890},
   keywords = {PERIPHERAL NEUROPATHY; NORMATIVE DATA; SKIN BIOPSY; DIAGNOSIS},
   language = {eng},
   issn = {0742-3071},
   journal = {Diabetic Medicine},
   title = {Intraepidermal nerve-fibre density as a biomarker of the course of neuropathy in patients with Type2 diabetes mellitus},
   volume = {33},
   year = {2016}
}

TY  - JOUR
ID  - 1353344
AU  - Divišová, Šárka - Vlčková, Eva - Šrotová, Iva - Kincová, Soňa - Skorna, M. - Dušek, Ladislav - Dubový, Petr - Bednařík, Josef
PY  - 2016
TI  - Intraepidermal nerve-fibre density as a biomarker of the course of neuropathy in patients with Type2 diabetes mellitus
JF  - Diabetic Medicine
VL  - 33
IS  - 5
SP  - 650-654
EP  - 650-654
PB  - Wiley-Blackwell
SN  - 07423071
KW  - PERIPHERAL NEUROPATHY
KW  - NORMATIVE DATA
KW  - SKIN BIOPSY
KW  - DIAGNOSIS
N2  - Aims This paper aims to investigate whether intraepidermal nerve-fibre density (IENFD) may be used as a marker of the course of neuropathy in patients with Type2 diabetes mellitus. Methods Skin biopsies from the distal leg were serially evaluated in a group of 30 patients with Type2 diabetes mellitus (median age 60years, 17 men) with a short duration of diabetes (<3years) and good glucose control, and in 23 age- and sex-matched controls. The time intervals between biopsies were >2years (median 33.8months). Eighteen patients with Type2 diabetes mellitus had symptoms or signs of distal symmetrical diabetic polyneuropathy, 12 had no neuropathy. Results At first skin biopsy, IENFD was normal in all controls and in patients without neuropathy (mean 9.5 and 7.9fibres/mm, respectively) compared with abnormal IENFD in 77.8% in patients with polyneuropathy (mean 3.4fibres/mm). The annual rate of intraepidermal nerve-fibre (IENF) loss expressed as a percentage of the first IENFD value in patients with diabetic polyneuropathy was significantly higher [mean (se), 11.95 (3.82)%] compared with controls [1.92 (1.81)%, P<0.001] and similar to patients without polyneuropathy [12.16 (4.38)%]. The rate of IENF loss did not correlate with degree of glucose control. Conclusions The annual rate of IENF loss in patients with Type2 diabetes mellitus was several times higher than that of healthy participants, irrespective of the presence of signs or symptoms of diabetic polyneuropathy at initial evaluation. The change in IENFD is not linear and should be expressed as a proportion of initial IENFD to serve as a marker of the course of diabetic neuropathy. What's new? Intraepidermal nerve-fibre loss in patients with Type2 diabetes mellitus is not linear and should be expressed as a proportion of initial intraepidermal nerve-fibre density. Annual intraepidermal nerve-fibre loss as a marker of the progression of small-fibre neuropathy in patients with Type2 diabetes mellitus is several times higher compared with age-related intraepidermal nerve-fibre loss in age- and sex-matched people without diabetes. Change in intraepidermal nerve-fibre density in patients with Type2 diabetes mellitus of short duration and good glucose control is not dependent on the presence of neuropathy and degree of glucose control.
ER  -

DIVIŠOVÁ, Šárka; Eva VLČKOVÁ; Iva ŠROTOVÁ; Soňa KINCOVÁ; M. SKORNA; Ladislav DUŠEK; Petr DUBOVÝ a Josef BEDNAŘÍK. Intraepidermal nerve-fibre density as a biomarker of the course of neuropathy in patients with Type2 diabetes mellitus. \textit{Diabetic Medicine}. Hoboken: Wiley-Blackwell, 2016, roč.~33, č.~5, s.~650-654. ISSN~0742-3071. Dostupné z: https://doi.org/10.1111/dme.12890.

Přehled o publikaci